ResMed (RMD) Misses Q2 EPS by 5c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $219.58 --0%
EPS Growth %: +5.5%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: +5.5%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.47, $0.05 worse than the analyst estimate of $1.52. Revenue for the quarter came in at $894.9 million versus the consensus estimate of $935.3 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Lightpath Technologies (LPTH) Misses Q4 EPS by 5c
- KeyBanc Starts Eastman Chemical (EMN) at Sector Weight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
